Individualized everolimus treatment for tuberous sclerosis-related angiomyolipoma promotes treatment adherence and response.
Clin Kidney J
; 15(6): 1160-1168, 2022 Jun.
Article
in En
| MEDLINE
| ID: mdl-35754971
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Guideline
Language:
En
Journal:
Clin Kidney J
Year:
2022
Document type:
Article
Affiliation country:
United kingdom